All In Biotech

Drug Trial Radar · NCT01132690

A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

A Multicenter, Double-blind, Randomized Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

Last checked: Nov 20, 2026Latest source record: Oct 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

11

Actual

Start

Aug 2010

Primary completion

May 2012

Study completion Jul 2012

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 28, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, double-blind trial to assess the safety and efficacy of taliglucerase alfa in untreated subjects (2 to \<18 years old) with Gaucher disease randomly assigned to treatment with one of two doses, 30 or 60 units/kg. Subjects will receive an intravenous (IV) infusion of taliglucerase alfa every two weeks. The total duration of treatment will be 12 months. At the end of the 12-month treatment period eligible subjects will be offered enrollment in an open-label extension study if taliglucerase alfa is not commercially available.

Conditions

  • Gaucher Disease

Interventions

  • Taliglucerase alfaDrug

    Taliglucerase alfa for infusion every two weeks for 12 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HemoglobinTime frame: Every 3 months for 12 months

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Instituto Privado de Hematologia E Investigacion Clinica (I.P.H.I.C)

    Barrio Sajonia Asunción, Paraguay

  • Morningside Medi-Clinic

    Morningside, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.